Related Experiment Video
Updated: Apr 15, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
HLA-B27
1Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Science (NDORMS), Botnar Research Center, University of Oxford, Headington, Oxford OX3 9DL, United Kingdom;
Human leukocyte antigen (HLA)-B27 is linked to ankylosing spondylitis (AS). This review explores how HLA-B27’s normal function and abnormal behavior may cause AS immunopathology.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- The human leukocyte antigen (HLA)-B27 molecule is strongly associated with ankylosing spondylitis (AS).
- The precise pathogenic role of HLA-B27 in AS development remains unclear.
- Current hypotheses involve HLA-B27's immunological functions and its aberrant behavior.
Purpose of the Study:
- To review the natural immunological function of HLA-B27.
- To discuss the known disease associations of HLA-B27.
- To explore current theories on the pathogenic mechanisms of HLA-B27 in AS.
Main Methods:
- Literature review of immunological and genetic studies.
- Analysis of proposed molecular mechanisms.
- Synthesis of current hypotheses on HLA-B27's role in AS.
Main Results:
- HLA-B27 presents antigenic peptides to cytotoxic T cells, potentially triggering autoimmune responses.
- Misfolding of HLA-B27 can induce endoplasmic reticulum stress and autophagy.
- Aberrant forms, like β2m-free heavy chains and homodimers (B272), can interact with innate immune receptors, promoting inflammation.
Conclusions:
- HLA-B27's pathogenic role in AS is likely multifactorial.
- Both its normal antigen presentation function and its aberrant cellular behavior contribute to AS pathogenesis.
- Further research is needed to fully elucidate the mechanisms linking HLA-B27 to AS.
More Related Videos
08:27Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021